# KLOW Peptide Dosage and Frequency: What Blend Listings and Component Papers Imply
> Note: PeptIQ is not a medical provider. This article is educational only. It is not a protocol and not advice to obtain or administer any blend.
KLOW is a research-vial nickname for a three-peptide recovery blend, usually discussed as BPC-157 plus TB-500 plus GHK-Cu in one cake. There is no randomized trial of "KLOW" as a labeled product. Dosage threads therefore borrow milligram slogans from the three components and from supplier listings.
The existing KLOW blend explainer on this site covers composition and when people split vials. This page stays on the search cluster around KLOW peptide dosage, how often, and protocol length.
Evidence tier
| Layer | What it can support | What it cannot |
|---|
| Component papers | Separate biologies for BPC-157, thymosin beta-4, and GHK-Cu | A blended milligram calendar |
| Supplier listings | Claimed fill weights and suggested pin counts | Identity or potency of the cake |
| Community and in-app logs | Frequency people record | Efficacy |
BPC-157 reviews remain preclinical-heavy (PubMed 29569996). Thymosin beta-4 wound-healing reviews describe the parent peptide, not every TB-500 fragment listing (PubMed 20507180). GHK-Cu has a broader skin and gene-expression literature, still not a blend schedule.
What "a dose" usually means on a listing
Blend vials are sold as a single lyophilized mass. Educational math still uses:
Concentration = labeled total milligrams ÷ diluent milliliters
That total is not one peptide. A draw labeled "one dose" on a forum is a share of whatever ratio the filler used. Change the water volume and the unit count moves even if the story stays "same dose."
Illustrative listing math, not a protocol
If a vial is described as a multi-milligram blend and someone adds 2 mL bacteriostatic water, community write-ups often treat 0.2–0.5 mL as a "typical draw." Those volumes only mean something if the label ratio is true. They are not a recommended mix.
Frequency people discuss
| Context people name | Cadence they repeat | Honest reading |
|---|
| Acute recovery story | Several days per week, sometimes daily | Uncontrolled habit |
| Maintenance story | 2–3 days per week | Uncontrolled habit |
| Cycle length story | 8–12 weeks, then time off | Forum calendar, not a trial arm |
PeptIQ users who log KLOW often record fewer weekly events than users who log BPC-157 alone, because the blend is treated as a single pin. That is a logging pattern. It is not evidence the blend outperforms separate vials.
"How often to take KLOW peptide" has no literature answer. Component half-life stories conflict: BPC-157 is discussed as shorter-acting, TB-500 as less frequent, GHK-Cu as daily or cycled. Stuffing three stories into one syringe does not reconcile them.
What to read instead of a pin calendar
- Component reconstitution pages for BPC-157, TB-500, and GHK-Cu when someone is actually holding separate vials
- The KLOW blend guide for composition and edema notes
- Mixing-in-one-syringe education for chemistry risk, not convenience scoring
Bottom line
KLOW dosage tables are blend-listing folklore. Frequency charts are community calendars. The papers belong to the three components, not to a trademarked stack name. Educational use only.
